We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SUNNYVALE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients...
—Ms. Rodenbush to lead hiring and talent development initiatives— —Mr. Price to focus on market development and penetration— SUNNYVALE, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc...
SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients...
—Ceribell System stands to reduce costly ICU admissions and intra-facility patient transfers— —Military veterans face elevated risks of developing seizure disorders— SUNNYVALE, Calif., Nov. 11...
SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients...
Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 PR Newswire SUNNYVALE, Calif., Oct. 29, 2024 SUNNYVALE, Calif., Oct. 29, 2024 /PRNewswire/ -- Ceribell, Inc. (Nasdaq:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.955 | -3.48095498451 | 27.435 | 28.23 | 25.75 | 782756 | 26.89289173 | CS |
4 | -2.5 | -8.62663906142 | 28.98 | 32.535 | 25.75 | 319464 | 27.68138916 | CS |
12 | 3.22 | 13.8435081685 | 23.26 | 32.535 | 23 | 275765 | 26.8206679 | CS |
26 | 3.22 | 13.8435081685 | 23.26 | 32.535 | 23 | 275765 | 26.8206679 | CS |
52 | 3.22 | 13.8435081685 | 23.26 | 32.535 | 23 | 275765 | 26.8206679 | CS |
156 | 3.22 | 13.8435081685 | 23.26 | 32.535 | 23 | 275765 | 26.8206679 | CS |
260 | 3.22 | 13.8435081685 | 23.26 | 32.535 | 23 | 275765 | 26.8206679 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions